Monographie - Colistin mesilate sodium

Última actualização :
08/05/2024

Colistin mesilate sodium

Estrutura química

Nomes comerciais nos diversos países

OS NOMES COMERCIAIS SÃO INDICATIVOS E OS EXCIPIENTES DA FORMULAÇÃO PODEM SER DIFERENTES CONFORME O PAÍS E FABRICANTE.

Alfacolin	Argentina
Alficetin	Argentina
Colent	Chilli
Colimicina	Espanha, Itália
Colimycin	Dinamarca, Noruega, Turquia
Colimycine	França, Luxemburgo, Marrocos, Países Baixos, Tunísia
Colismet	Peru
Colisti Ject	Egipto
Colistimetal sodic	Romènia
Colistimetato de sodio	Chilli, Espanha, Peru
Colistimethate	Canadá, Estados Unidos de América, Gran-bretanha
Colistin	Austria, Grècia, Nova Zelândia, Polonia
Colistina	Argentina, Portugal
Colistineb	Bélgica
Colistyn	Argentina
Colixin	Portugal
Colomycin	Canadá, Estados Unidos de América, Gran-bretanha, Irlanda, Malásia
Coly-Mycin	Australia, Estados Unidos de América
Cotrelan	Argentina
Dicupal	Chilli
Elistin	Peru
Kolisod	Turquia
Nolisin	Argentina
Promixin	Gran-bretanha, Irlanda, Noruega
Toliscrin	Argentina

Bibliografía : Colistin mesilate sodium

	Tipo	Publicação
1201	Jornal	Yuhas EM, Lofton FT, Rosenberg HA, Mayron D, Baldinus JG. Cimetidine hydrochloride compatibility III: Room temperature stability in drug admixtures. Am J Hosp Pharm 1981 ; 38: 1919-1922.
2285	Jornal	Wallace SJ, Li J, Rayner CR, Coulthard K, Nation RL. Stability of colistin methanesulfonate in pharmaceutical products and solutions for administration to patients. Antimicrob Agents Chemother 2008 ; 52, 9: 3047-3051.
2550	Jornal	Roberts GW, Rossi S.O.P. Compatibility of nebulizer solutions Aust J Hosp Pharm 1993 ; 23: 35-37.
2783	Jornal	Abdulla A,.van Leeuwen R.W.F, de Vries Schultink A.H.M,.Koch B.C.P. Stability of colistimethate sodium in a disposable elastomeric infusion device. Int J Pharm 2015 ; 486; 1-2: 367-369.
3254	Jornal	Housman S.T, Tessier P.R, Nicolau D.P, Kuti J.L. Physical compatibility of telavancin hydrochloride with select i.v. drugs during simulated Y-site administration Am J Health-Syst Pharm 2011 ; 68: 2265-2270.
3360	Jornal	Healan A. M, Gray W, Fuchs E.J, Griffiss J.M, Salata R.A, Blumer J. Stability of Colistimethate Sodium in Aqueous Solution. Antimicrob Agents Chemother 2012 ; 56:6432-6433.
3674	Laboratório	Erythromycin lactobionate - Summary of Product Characteristics PanPharma 2016
3827	Poster	Ghazi I.M, Hamada Y, Nicolau D.P. Compatibility of tedizolid phosphate with selected intravenous drugs via simulated Y-site conditions. ASHP Midyear 2015
3828	Poster	Thabit A.K, Hamada Y, Nicolau D.P. Ceftozolane/tazobactam physical compatibility during simulated Y-site administration. ASHP Midyear 2015
3829	Poster	So W, Kim L, Thabit A.K, Nicolau D.P, Kuti J.L. Compatibility of isavunazonium sulfate during simulated Y-site administration. ASHP Midyear 2015
3997	Jornal	Katip W. Visual compatibility of colistin injection with other antibiotics during simulated Y-site administration. Am J Health-Syst Pharm 2017 ; 74:14 : 1099-1102
4055	Jornal	Monogue M, Almarzoky Abuhussain S, Kuti J, Nicolau D. Physical compatibility of fosfomycin for injection with select i.v. drugs during simulated Y-site administration. Am J Health-Syst Pharm 2018 , 75, 1:36-44
4145	Jornal	Asempa T.E, Avery L.M, Kidd J.M, Kuti J.L, Nicolau D.P. Physical compatibility of plazomicin with select i.v. drugs during simulated Y-site administration. Am J Health-Syst Pharm 2018 ;75,14:1048-1056
4178	Jornal	Post T.E, Kamerling I, van Rossen R, Burggraaf J, Stevens J, Dijkmans A, Heijerman H, Touw D, van Velzen A, Wilms E. Colistin methanesulfonate infusion solutions are stable over time and suitable for home administration. EJHP 2017 ; 25, e2
4319	Jornal	Lessard J-J, Caron E, Schérer H, Forest J-M, Leclair G. Compatibility of Y-site Injection of Meropenem Trihydrate With 101 Other Injectable Drugs. Hosp Pharm 2020 ; 55, 5: 332-337.
4434	Jornal	Avery L.M, Chen, I.H, Reyes, S, Nicolau, D.P, Kuti J.L. Assessment of the Physical Compatibility of Eravacycline and Common Parenteral Drugs During Simulated Y-site Administration. Clin Ther 2019 ; 41, 10: 2162-2170.
4438	Jornal	Stawny M, Gostyńska A, Nadolna M, Jelińska A. Safe Practice of Y-Site Drug Administration: The Case of Colistin and Parenteral Nutrition Pharmaceutics 2020 ; 12: 292
4528	Jornal	Lu J, Liu Q, Kupiec T, Vail H, Lunch L, Fam D, Vu N. Physical Compatibility of Cefiderocol with Selected Intravenous Drugs During Simulated Y-site Administration. Int J Pharm Compound 2021 ;25,1:52-61
4801	Jornal	Ruiz V, Yuwei Shen Y, Abouelhassan Y, Fouad A, Nicolau D, Kuti J. Physical compatibility of sulbactam/durlobactam with select intravenous drugs during simulated Y-site administration. Am J Health-Syst Pharm 2024 ;51,1:

Mentions Légales